Chemoradiotherapy trials for Lung cancer

All Chemoradiotherapy trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Chemoradiotherapy for Lung cancer

• COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
  NCT05258448 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
  NCT06810609 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 5 locations
• Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
  NCT07264647 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
  NCT04913311 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location

Common questions

How many trials study Chemoradiotherapy for Lung cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.